Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INGR
INGR logo

INGR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
108.462
Open
107.620
VWAP
106.40
Vol
1.08M
Mkt Cap
6.70B
Low
104.370
Amount
115.25M
EV/EBITDA(TTM)
6.42
Total Shares
63.00M
EV
7.63B
EV/OCF(TTM)
8.48
P/S(TTM)
0.96
Ingredion Incorporated is a global ingredient solutions provider serving customers in nearly 120 countries. The Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. Its segments include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients - Latin America (F&II - LATAM) and Food & Industrial Ingredients - U.S./Canada (F&II - U.S./Canada). Its product lines include starches and sweeteners, animal feed products and edible corn oil. Its starch-based products include both food-grade and industrial starches, as well as biomaterials and non-GMO (genetically modified organism) products. Its sweetener products include glucose syrups, high maltose syrups, high fructose corn syrup, caramel color, dextrose, polyols, maltodextrins, glucose and syrup solids, high-intensity sweeteners, and various non-GMO products.
Show More

Events Timeline

(ET)
2026-05-05
06:20:00
Company Expects Q2 2026 Net Sales Flat to Low Single-Digit Growth
select
2026-05-05
06:20:00
Company Expects FY26 Net Sales Flat to Low Single-Digit Growth
select
2026-05-05
06:10:00
Ingredion Q1 Revenue Matches Expectations at $1.79B
select
2026-03-25 (ET)
2026-03-25
06:50:00
Ingredion Appoints Jason Payant as Interim CFO
select
2026-03-18 (ET)
2026-03-18
10:40:00
Shiru and Ingredion Collaborate on R&D for Novel Functional Proteins
select

News

seekingalpha
9.5
05-04seekingalpha
PinnedIngredion Set to Announce Q1 Earnings on May 5
  • Earnings Announcement Date: Ingredion (INGR) is scheduled to announce its Q1 2023 earnings on May 5 before market open, with consensus EPS estimate at $2.47, reflecting a 16.8% year-over-year decline, which could negatively impact investor sentiment.
  • Revenue Decline Expected: The anticipated revenue for Q1 is $1.79 billion, down 1.1% year-over-year, indicating challenges the company faces in the current economic environment, potentially affecting its future market performance.
  • Historical Performance Review: Over the past two years, Ingredion has only beaten EPS estimates 75% of the time and has never exceeded revenue estimates, highlighting ongoing pressures on the company's profitability and revenue growth.
  • Management Change: Jason Payant was appointed interim CFO effective April 1, a change that may influence the company's financial strategy and investor confidence during a critical period of transformation and growth.
seekingalpha
9.5
05-05seekingalpha
Ingredion Q1 Earnings Miss Expectations with EPS Guidance Adjusted
  • Earnings Performance: Ingredion's Q1 non-GAAP EPS of $2.34 missed expectations by $0.13, indicating pressure on profitability that could undermine investor confidence and stock performance.
  • Revenue Decline: The company reported revenue of $1.79 billion, a slight year-over-year decrease of 1.1%, which, while in line with expectations, suggests a lack of sales growth that may impact future market competitiveness.
  • Guidance Adjustment: Ingredion adjusted its full-year EPS guidance to a range of $9.60 to $10.30, with adjusted EPS guidance set at $10.45 to $11.15, falling short of the $11.33 consensus, reflecting a cautious outlook on future performance.
  • Stock Reaction: Following the earnings report, Ingredion's shares fell by 4%, indicating market concerns regarding the company's performance and future prospects, which may lead investors to reassess their investment strategies.
CNBC
6.0
04-01CNBC
Sensient Technologies Set for Growth as Shift to Natural Dyes Accelerates
  • Market Transformation Opportunity: According to UBS, U.S. food producers and grocers are transitioning from synthetic dyes to natural colorants, which is expected to create significant growth opportunities for Sensient Technologies, with analyst Joshua Spector noting this shift will act as a positive catalyst for the company's stock.
  • Price Target Increase: UBS initiated coverage with a buy rating on Sensient, setting a price target of $115, implying a 33% upside from Tuesday's close, reflecting confidence in the company's future growth potential.
  • Sales Growth Expectations: By 2030, Sensient's color group sales are projected to increase by over 200% due to the growing adoption of natural food colorings, significantly enhancing the company's market share and profitability, particularly in North America.
  • Analyst Consensus: Among the three analysts covering Sensient, two have assigned strong buy or buy ratings, indicating a general optimism about the company's future performance, despite its shares having fallen nearly 3% year-to-date.
CNBC
5.0
03-25CNBC
Jim Cramer's Trust Increases Stake in Cardinal Health
  • Increased Stake: Jim Cramer's Charitable Trust purchased 25 shares of Cardinal Health at approximately $210, raising its total holdings to 475 shares and increasing its portfolio weighting from 2.5% to 2.6%, reflecting confidence in the company.
  • Market Reaction: Cardinal Health's stock has pulled back about 9% since the onset of the conflict with Iran; however, the company is expected to see earnings per share grow approximately 25% in the current fiscal year, indicating strong profitability amid market volatility.
  • Product Growth: Sales of GLP-1 medications have provided a significant tailwind to Cardinal's Pharmaceutical and Specialty Solutions business, contributing 6 percentage points to revenue growth in the most recent quarter, further solidifying its market position.
  • Board Changes: The sudden retirement of Chairman Gregory Kenny, replaced by current director Patricia Hemingway Hall, may unsettle investors; however, the company clarified that this decision was not related to operational disagreements and maintains confidence in its future financial outlook.
seekingalpha
5.0
03-25seekingalpha
Ingredion Appoints Interim CFO Jason Payantas Effective April 2026
  • Executive Change: Ingredion announced that Jason Payantas will serve as interim Chief Financial Officer starting April 1, 2026, succeeding James D. Gray, who will step down at the end of March, ensuring continuity and stability in financial management.
  • Background: Payantas has been with Ingredion since 2012, holding various key positions, most recently as Vice President of Finance for Global Texture & Healthful Solutions since November 2025, demonstrating his extensive experience and capability within the company.
  • Financial Outlook: Ingredion anticipates earnings per share in the range of $11 to $11.80 for 2026, indicating confidence in its growth initiatives related to clean label and protein fortification, reflecting a positive outlook on future market demand.
  • Strategic Transformation: This executive change aligns with the company's ongoing transformation strategy aimed at enhancing its competitiveness in high-yield and defensive investment sectors, further driving long-term growth.
CNBC
6.5
03-19CNBC
AI Sparks Potential Blue-Collar Renaissance Amid Job Disruption Fears
  • Blue-Collar Employment Revival: Oppenheimer analysts suggest that while AI may rapidly displace white-collar jobs, it could simultaneously drive demand for blue-collar roles, particularly in manufacturing, with employment projected to remain below pre-pandemic levels by 2026.
  • Investment Theme Analysis: Oppenheimer outlined five investable themes, including the physical-to-digital connection, emphasizing the value of sensors and data pipelines, with companies in this space expected to benefit from automation trends, including Aeva Technologies and Tesla.
  • Automation Tools Opportunity: The analysts identified automation tools that can reskill transitioning workforces, recommending companies like Caterpillar and Rockwell Automation, which enhance worksite experiences through task automation and AI agents.
  • Autonomous Systems Development: Oppenheimer also highlighted companies supporting autonomous physical systems, such as Mobileye Global and Aurora Innovation, noting that as fully autonomous solutions are commercialized, human roles will still be essential for remote monitoring and maintenance to ensure safety and problem resolution.
Wall Street analysts forecast INGR stock price to rise
4 Analyst Rating
Wall Street analysts forecast INGR stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
119.00
Averages
125.50
High
136.00
Current: 0.000
sliders
Low
119.00
Averages
125.50
High
136.00
Barclays
Benjamin Theurer
Equal Weight
downgrade
$128 -> $120
AI Analysis
2026-05-06
New
Reason
Barclays
Benjamin Theurer
Price Target
$128 -> $120
AI Analysis
2026-05-06
New
downgrade
Equal Weight
Reason
Barclays analyst Benjamin Theurer lowered the firm's price target on Ingredion to $120 from $128 and keeps an Equal Weight rating on the shares.
Oppenheimer
Kristen Owen
Outperform
maintain
$130 -> $126
2026-04-22
Reason
Oppenheimer
Kristen Owen
Price Target
$130 -> $126
2026-04-22
maintain
Outperform
Reason
Oppenheimer analyst Kristen Owen lowered the firm's price target on Ingredion to $126 from $130 and keeps an Outperform rating on the shares. The firm adjusted targets in the agriculture space as part of a Q1 preview. The analyst expects "healthy" Q1 results across its coverage, citing stabilization trends before the outbreak of the Iran conflict. "Sentiment in the industry remains resilient, with all eyes on the potential for fundamentals to diverge as the effects of higher-for-longer energy and fertilizer prices ripple through our coverage," the analyst tells investors in a research note. Oppenheimer has a cautious stance on Ingredion in the near-term.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for INGR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Ingredion Inc (INGR.N) is 9.39, compared to its 5-year average forward P/E of 11.88. For a more detailed relative valuation and DCF analysis to assess Ingredion Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
11.88
Current PE
9.39
Overvalued PE
13.10
Undervalued PE
10.66

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
7.62
Current EV/EBITDA
6.26
Overvalued EV/EBITDA
8.32
Undervalued EV/EBITDA
6.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.91
Current PS
0.89
Overvalued PS
1.07
Undervalued PS
0.76

Financials

AI Analysis
Annual
Quarterly

Whales Holding INGR

I
Invenomic Capital Management LP
Holding
INGR
+12.19%
3M Return
L
Leeward Investments, LLC
Holding
INGR
+11.27%
3M Return
Z
ZWJ Investment Counsel Inc
Holding
INGR
+9.39%
3M Return
A
AssetMark, Inc.
Holding
INGR
+8.78%
3M Return
S
Snyder Capital Management, L.P.
Holding
INGR
+2.85%
3M Return
Y
Yacktman Asset Management LP
Holding
INGR
+1.26%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ingredion Inc (INGR) stock price today?

The current price of INGR is 106.37 USD — it has decreased -0.71

What is Ingredion Inc (INGR)'s business?

Ingredion Incorporated is a global ingredient solutions provider serving customers in nearly 120 countries. The Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. Its segments include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients - Latin America (F&II - LATAM) and Food & Industrial Ingredients - U.S./Canada (F&II - U.S./Canada). Its product lines include starches and sweeteners, animal feed products and edible corn oil. Its starch-based products include both food-grade and industrial starches, as well as biomaterials and non-GMO (genetically modified organism) products. Its sweetener products include glucose syrups, high maltose syrups, high fructose corn syrup, caramel color, dextrose, polyols, maltodextrins, glucose and syrup solids, high-intensity sweeteners, and various non-GMO products.

What is the price predicton of INGR Stock?

Wall Street analysts forecast INGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGR is125.50 USD with a low forecast of 119.00 USD and a high forecast of 136.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ingredion Inc (INGR)'s revenue for the last quarter?

Ingredion Inc revenue for the last quarter amounts to 1.79B USD, decreased -1.16

What is Ingredion Inc (INGR)'s earnings per share (EPS) for the last quarter?

Ingredion Inc. EPS for the last quarter amounts to 2.22 USD, decreased -26.00

How many employees does Ingredion Inc (INGR). have?

Ingredion Inc (INGR) has 11200 emplpoyees as of May 07 2026.

What is Ingredion Inc (INGR) market cap?

Today INGR has the market capitalization of 6.70B USD.